The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
- PMID: 16698746
- PMCID: PMC1856208
- DOI: 10.1136/gut.2005.082909
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
Abstract
In recent years, investigators have readdressed the complex issues involved in the classification of inflammatory bowel diseases. In 2003, a Working Party of investigators with an interest in the issues involved in disease subclassification was formed with the aim of summarising recent developments in disease classification and establishing an integrated clinical, molecular, and serological classification of inflammatory bowel disease. The results of the Working Party were reported at the 2005 Montreal World Congress of Gastroenterology. Here we highlight the key issues that have emerged from discussions of the Montreal Working Party and the relevance to clinical practice and research activities.
Conflict of interest statement
Conflict of interest: None declared.
Comment in
-
Is ileocaecal Crohn's disease L1 or L3 according to the Montreal classification?Gut. 2008 Mar;57(3):427. doi: 10.1136/gut.2007.140939. Gut. 2008. PMID: 18268062 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical